{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T04:06:47Z","timestamp":1770610007161,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/bf00686329","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T08:44:58Z","timestamp":1101717898000},"page":"13-18","source":"Crossref","is-referenced-by-count":43,"title":["Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs"],"prefix":"10.1007","volume":"29","author":[{"given":"J. Catharine R.","family":"Scott-Moncrieff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C. K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra L.","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon L.","family":"Coppoc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis B.","family":"DeNicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph C.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"241","volume":"49","author":"VI Avramis","year":"1989","unstructured":"Avramis VI, Weinberg KI, Sato JK, Lenarsky C, Willoughby ML, Coates TD, Ozkaynak MF, Parkman R (1989) Pharmacology studies of 1?-d-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug. Cancer Res 49: 241?247","journal-title":"Cancer Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1097-0142(197310)32:4<744::AID-CNCR2820320402>3.0.CO;2-J","volume":"32","author":"PR Band","year":"1973","unstructured":"Band PR, Holland JF, Bernard J, Weil M, Walker M, Rall D (1973) Treatment of central nervous system leukemia with intrathecal cytosine arabinoside. Cancer 32: 744?748","journal-title":"Cancer"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/1097-0142(19821001)50:7<1248::AID-CNCR2820500705>3.0.CO;2-5","volume":"50","author":"H Breithaupt","year":"1982","unstructured":"Breithaupt H, Pralle H, Eckhardt T, Von Hattingberg M, Schick J, Loffler H (1982) Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C). Cancer 50: 1248?1257","journal-title":"Cancer"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1200\/JCO.1983.1.12.763","volume":"1","author":"RL Capizzi","year":"1983","unstructured":"Capizzi RL, Yang JL, Cheng E, Bjornsson T, Sahasrabudhe D, Tan RS, Cheng Y-C (1983) Alteration of the pharmacokinetics of high-dose ara-C by its metabolite ara-U in patients with acute leukemia. J Clin Oncol 1: 763?771","journal-title":"J Clin Oncol"},{"key":"CR5","first-page":"1","volume":"14","author":"R Champlin","year":"1987","unstructured":"Champlin R, Ho W, Winston D, Decker R, Greenberg P, Burnison M, Holly FE, Gale RP (1987) Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation. Semin Oncol 14: 1?6","journal-title":"Semin Oncol"},{"key":"CR6","first-page":"809","volume":"184","author":"CG Couto","year":"1984","unstructured":"Couto CG, Cullen J, Pedroia V, Turrel JM (1984) Central nervous system lymphosarcoma in the dog. J Am Vet Med Assoc 184: 809?813","journal-title":"J Am Vet Med Assoc"},{"key":"CR7","first-page":"283","volume":"4","author":"SE Crow","year":"1982","unstructured":"Crow SE (1982) Lymphosarcoma (malignant lymphoma) in the dog: diagnosis and treatment. Compend Cont Educ Pract 4: 283?289","journal-title":"Compend Cont Educ Pract"},{"key":"CR8","first-page":"267","volume":"8","author":"LE Damon","year":"1989","unstructured":"Damon LE, Linker CA (1989) Comparison of plasma and cerebrospinal fluid pharmacokinetics of high-dose versus intermediatedose cytosine arabinoside (abstract). Proceedings, Annual Meeting of the American Society of Clinical Oncologists, 8, p 267","journal-title":"Proceedings, Annual Meeting of the American Society of Clinical Oncologists"},{"key":"CR9","first-page":"2210","volume":"43","author":"JR DeLoach","year":"1982","unstructured":"DeLoach JR, Barton C (1982) Circulating carrier erythrocytes: slow-release vehicle for an antileukemic drug, cytosine arabinoside. Am J Vet Res 43: 2210?2212","journal-title":"Am J Vet Res"},{"key":"CR10","first-page":"1587","volume":"42","author":"AP Early","year":"1982","unstructured":"Early AP, Preisler HD, Slocum H, Rustum YM (1982) A pilot study of high-dose 1-?-d-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. Cancer Res 42: 1587?1594","journal-title":"Cancer Res"},{"key":"CR11","first-page":"324","volume":"222","author":"H Ellens","year":"1982","unstructured":"Ellens H, Rustum Y, Mayhew E, Ledesma E (1982) Distribution and metabolism of liposome-encapsulated and free 1-?-d-arabinofuranosylcytosine (ara-C) in dog and mouse tissues. J Pharmacol Exp Ther 222: 324?330","journal-title":"J Pharmacol Exp Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JCO.1984.2.5.365","volume":"2","author":"J Frick","year":"1984","unstructured":"Frick J, Ritch PS, Hansen RM, Anderson T (1984) Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside. J Clin Oncol 2: 365?368","journal-title":"J Clin Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00254052","volume":"8","author":"DS Fulton","year":"1982","unstructured":"Fulton DS, Levin VA, Gutin PH, Edwards MSB, Seager ML, Stewart J, Wilson CB (1982) Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors. Cancer Chemother Pharmacol 8: 285?291","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM197905243002105","volume":"300","author":"RP Gale","year":"1979","unstructured":"Gale RP (1979) Advances in the treatment of acute myelogenous leukemia. N Engl J Med 300: 1189?1199","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/clpt.1982.93","volume":"31","author":"KR Hande","year":"1982","unstructured":"Hande KR, Stein RS, McDonough DA, Greco FA, Wolff SN (1982) Effects of high-dose cytarabine. Clin Pharmacol Ther 31: 669?674","journal-title":"Clin Pharmacol Ther"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2125.1979.tb01005.x","volume":"8","author":"AL Harris","year":"1979","unstructured":"Harris AL, Potter C, Bunch C, Boutagy J, Harvey DJ, Grahame-Smith DG (1979) Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia. Br J Clin Pharmacol 8: 219?227","journal-title":"Br J Clin Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/1097-0142(197901)43:1<390::AID-CNCR2820430155>3.0.CO;2-U","volume":"43","author":"TS Herman","year":"1979","unstructured":"Herman TS, Hammond N, Jones SE, Butler JJ, Byrne GE, McKelvey EM (1979) Involvement of the central nervous system by non-Hodgkin's lymphoma. Cancer 43: 390?397","journal-title":"Cancer"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/cpt1971126944","volume":"12","author":"DHW Ho","year":"1971","unstructured":"Ho DHW, Frei E III (1971) Clinical pharmacology of 1-?-d-arabinofuranosylcytosine. Clin Pharmacol Ther 12: 944?954","journal-title":"Clin Pharmacol Ther"},{"key":"CR19","first-page":"309","volume":"3","author":"DHW Ho","year":"1975","unstructured":"Ho DHW, Carter CJK, Loo TL, Abbott RL, McBride CM (1975) Pharmacologic studies of cyclocytidine and arabinosylcytosine in dogs. Drug Metab Dispos 3: 309?313","journal-title":"Drug Metab Dispos"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3181\/00379727-122-31211","volume":"122","author":"HE Hoff","year":"1966","unstructured":"Hoff HE, Deavers S, Huggins RA (1966) Effects of hypertonic glucose and mannitol on plasma volume. Proc Soc Exp Biol Med 122: 630?634","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/1097-0142(197709)40:3<1304::AID-CNCR2820400346>3.0.CO;2-V","volume":"40","author":"IP Law","year":"1977","unstructured":"Law IP, Blom J (1977) Adult acute leukemia. Frequency of central nervous system involvement in long term survivors. Cancer 40: 1304?1306","journal-title":"Cancer"},{"key":"CR22","first-page":"2572","volume":"45","author":"L Perlow","year":"1985","unstructured":"Perlow L, Ohnuma T, Andrejczuk A, Shafir M, Strauchen J, Holland JF (1985) Pharmacology and toxicology of a seven-day infusion of 1-?-d-arabinofuranosylcytosine plus uridine in dogs. Cancer Res 45: 2572?2577","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"CR23","first-page":"279","volume":"1","author":"MB Regazzi","year":"1989","unstructured":"Regazzi MB, Rondanelli R, Morra E, Lazzarino M, Alessandrino EP, Bernasconi C (1989) Ara-C pharmacokinetics in meningeal leukemia treatment (abstract). J Chemother Infect Dis Malig 1 [Suppl 1]: 279","journal-title":"J Chemother Infect Dis Malig"},{"key":"CR24","first-page":"137","volume":"182","author":"KE Rohrig","year":"1983","unstructured":"Rohrig KE (1983) Acute myelomonocytic leukemia in a dog. J Am Vet Med Assoc 182: 137?141","journal-title":"J Am Vet Med Assoc"},{"issue":"Suppl 1","key":"CR25","first-page":"141","volume":"14","author":"YM Rustum","year":"1987","unstructured":"Rustum YM, Riva C, Preisler HD (1987) Pharmacokinetic parameters of 1-?-d-arabinofuranosylcytosine (ara-C) and their relationship to intracellular metabolism of ara-C, toxicity, and response of patients with acute non-lymphocytic leukemia treated with conventional and high-dose ara-C. Semin Oncol 14 [Suppl 1]: 141?148","journal-title":"Semin Oncol"},{"issue":"Suppl 1","key":"CR26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mpo.2950100715","volume":"10","author":"ML Slevin","year":"1982","unstructured":"Slevin ML, Piall EM, Aherne GW, Johnston A, Lister TA (1982) The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy. Med Pediatr Oncol 10 [Suppl 1]: 157?168","journal-title":"Med Pediatr Oncol"},{"key":"CR27","first-page":"304","volume":"2","author":"DR Spriggs","year":"1988","unstructured":"Spriggs DR, Robbins G, Arthur K, Mayer RJ, Kufe D (1988) Prolonged high-dose ara-C infusions in acute leukemia. Leukemia 2: 304?306","journal-title":"Leukemia"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0142(19810101)47:1<184::AID-CNCR2820470130>3.0.CO;2-M","volume":"47","author":"DJ Stewart","year":"1981","unstructured":"Stewart DJ, Keating MJ, McCredie KB, Smith TL, Youness E, Murphy SG, Bodey GP, Freirich EJ (1981) Natural history of central nervous system acute leukemia in adults. Cancer 47: 184?196","journal-title":"Cancer"},{"key":"CR29","first-page":"110","volume":"14","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ, Hugenholtz H, DaSilva V, Benoit B, Richard M, Russell N, Maroun J, Verma S (1987) Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas. Semin Oncol 14: 110?115","journal-title":"Semin Oncol"},{"issue":"Suppl 1","key":"CR30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mpo.2950100719","volume":"10","author":"MP Sullivan","year":"1982","unstructured":"Sullivan MP (1982) Use of cytosar in pediatric acute myelocytic leukemia and leukemic meningitis. Med Pediatr Oncol 10 [Suppl 1]: 193?200","journal-title":"Med Pediatr Oncol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-92-6-785","volume":"92","author":"DL Sweet","year":"1980","unstructured":"Sweet DL, Golomb HM, Ultman JE, Miller JB, Stein RS, Lester EP, Mintz U, Bitran JD, Streuli RA, Daly K, Roth NO (1980) Cyclophosphamide, vincristine, methotrexate with leucoverin rescue and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma. Ann Intern Med 92: 785?790","journal-title":"Ann Intern Med"},{"key":"CR32","first-page":"607","volume":"170","author":"GH Theilen","year":"1977","unstructured":"Theilen GH, Worley M, Benjamini E (1977) Chemoimmunotherapy for canine lymphosarcoma. J Am Vet Med Assoc 170: 607?610","journal-title":"J Am Vet Med Assoc"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/cpt1977216744","volume":"21","author":"R Prooijen Van","year":"1977","unstructured":"Van Prooijen R, Van der Kleijn E, Haanen C (1977) Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia. Clin Pharmacol Ther 21: 744?750","journal-title":"Clin Pharmacol Ther"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/1097-0142(197003)25:3<531::AID-CNCR2820250306>3.0.CO;2-G","volume":"25","author":"JJ Wang","year":"1970","unstructured":"Wang JJ, Pratt CB (1970) Intrathecal arabinosyl cytosine in meningeal leukemia. Cancer 25: 531?534","journal-title":"Cancer"},{"key":"CR35","first-page":"891","volume":"181","author":"RE Weller","year":"1982","unstructured":"Weller RE, Theilen GH, Madewell BR (1982) Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia. J Am Vet Med Assoc 181: 891?893","journal-title":"J Am Vet Med Assoc"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.3.5773.508","volume":"3","author":"JL Ziegler","year":"1971","unstructured":"Ziegler JL, Bluming AZ (1971) Intrathecal chemotherapy in Burkitt's lymphoma. BMJ 3: 508?512","journal-title":"BMJ"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00686329\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:10:52Z","timestamp":1554459052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00686329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1991]]}},"alternative-id":["BF00686329"],"URL":"https:\/\/doi.org\/10.1007\/bf00686329","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991]]}}}